idioma

Q4 2017 Seres Therapeutics Inc Earnings Call

8/3/2018 8:00

Llamada en conferencia Seres Therapeutics Inc

Seres Therapeutics Inc Conference call or earnings call will be held on 08-mar-2018 via an 800 number (toll-free). During the earnings conference call's session Seres Therapeutics Inc will provide updated information and financial status.

Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.

In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Seres Therapeutics Inc for this information

We are a microbiome therapeutics platform company developing a novel class of biological drugs, which we refer to as Ecobiotic microbiome therapeutics. The human microbiome is an ecology of microorganisms, including bacteria, fungi and viruses, that, when unhealthy, or dysbiotic, can leave the body more susceptible to infections, metabolic disorders, allergies, autoimmune disease, inflammation and other serious conditions. Our drugs are designed to restore health by repairing the function of a dysbiotic microbiome. We are initially focused on implementing our microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome, one of the most diverse microbiomes in the human body. SER-109, our lead product candidate, is designed to prevent further recurrences of Clostridium difficile infection, or CDI, a debilitating infection of the colon and, if approved by the U.S.